1.Heymans S, Gonzalez A, Pizard A, Papageorgiou AP, Lopez-Andres N, Jaisser F, Thum T, Zannad F and Diez J (2015) Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential. Eur J Heart Fail 17:764-71. doi: 10.1002/ejhf.312
2.Creemers EE and Pinto YM (2011) Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 89:265-72. doi: 10.1093/cvr/cvq308
3.de Boer RA, De Keulenaer G, Bauersachs J, Brutsaert D, Cleland JG, Diez J, Du XJ, Ford P, Heinzel FR, Lipson KE, McDonagh T, Lopez-Andres N, Lunde IG, Lyon AR, Pollesello P, Prasad SK, Tocchetti CG, Mayr M, Sluijter JPG, Thum T, Tschope C, Zannad F, Zimmermann WH, Ruschitzka F, Filippatos G, Lindsey ML, Maack C and Heymans S (2019) Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology. Eur J Heart Fail 21:272-285. doi: 10.1002/ejhf.1406
4.Shih YC, Chen CL, Zhang Y, Mellor RL, Kanter EM, Fang Y, Wang HC, Hung CT, Nong JY, Chen HJ, Lee TH, Tseng YS, Chen CN, Wu CC, Lin SL, Yamada KA, Nerbonne JM and Yang KC (2018) Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation. Circ Res 122:1052-1068. doi: 10.1161/CIRCRESAHA.117.312130
5.Driesen RB, Nagaraju CK, Abi-Char J, Coenen T, Lijnen PJ, Fagard RH, Sipido KR and Petrov VV (2014) Reversible and irreversible differentiation of cardiac fibroblasts. Cardiovasc Res 101:411-22. doi: 10.1093/cvr/cvt338
6.Yu J, Seldin MM, Fu K, Li S, Lam L, Wang P, Wang Y, Huang D, Nguyen TL, Wei B, Kulkarni RP, Di Carlo D, Teitell M, Pellegrini M, Lusis AJ and Deb A (2018) Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity. Circ Res 123:73-85. doi: 10.1161/CIRCRESAHA.118.312589
7.Travers JG, Kamal FA, Robbins J, Yutzey KE and Blaxall BC (2016) Cardiac Fibrosis: The Fibroblast Awakens. Circ Res 118:1021-40. doi: 10.1161/CIRCRESAHA.115.306565
8.Kong P, Christia P and Frangogiannis NG (2014) The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 71:549-74. doi: 10.1007/s00018-013-1349-6
9.Bernaba BN, Chan JB, Lai CK and Fishbein MC (2010) Pathology of late-onset anthracycline cardiomyopathy. Cardiovasc Pathol 19:308-11. doi: 10.1016/j.carpath.2009.07.004
10.Biernacka A and Frangogiannis NG (2011) Aging and Cardiac Fibrosis. Aging Dis 2:158-173.
11.de Couto G, Liu W, Tseliou E, Sun B, Makkar N, Kanazawa H, Arditi M and Marban E (2015) Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest 125:3147-62. doi: 10.1172/JCI81321
12.Weber KT, Sun Y, Bhattacharya SK, Ahokas RA and Gerling IC (2013) Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10:15-26. doi: 10.1038/nrcardio.2012.158
13.Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110:159-73. doi: 10.1161/CIRCRESAHA.111.243162
14.Blyszczuk P, Berthonneche C, Behnke S, Glonkler M, Moch H, Pedrazzini T, Luscher TF, Eriksson U and Kania G (2013) Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133(+) progenitors into F4/80(+) macrophages in experimental autoimmune myocarditis. Cardiovasc Res 97:219-29. doi: 10.1093/cvr/cvs317
15.Russell JO and Monga SP (2018) Wnt/beta-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology. Annu Rev Pathol 13:351-378. doi: 10.1146/annurev-pathol-020117-044010
16.Yang D, Fu W, Li L, Xia X, Liao Q, Yue R, Chen H, Chen X, An S, Zeng C and Wang WE (2017) Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction. Clin Sci (Lond) 131:2919-2932. doi: 10.1042/CS20171256
17.Tao H, Yang JJ, Shi KH and Li J (2016) Wnt signaling pathway in cardiac fibrosis: New insights and directions. Metabolism 65:30-40. doi: 10.1016/j.metabol.2015.10.013
18.Dzialo E, Rudnik M, Koning RI, Czepiel M, Tkacz K, Baj-Krzyworzeka M, Distler O, Siedlar M, Kania G and Blyszczuk P (2019) WNT3a and WNT5a Transported by Exosomes Activate WNT Signaling Pathways in Human Cardiac Fibroblasts. Int J Mol Sci 20. doi: 10.3390/ijms20061436
19.Duan J, Gherghe C, Liu D, Hamlett E, Srikantha L, Rodgers L, Regan JN, Rojas M, Willis M, Leask A, Majesky M and Deb A (2012) Wnt1/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO J 31:429-42. doi: 10.1038/emboj.2011.418
20.Xiang FL, Fang M and Yutzey KE (2017) Loss of beta-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice. Nat Commun 8:712. doi: 10.1038/s41467-017-00840-w
21.Miao J, Liu J, Niu J, Zhang Y, Shen W, Luo C, Liu Y, Li C, Li H, Yang P, Liu Y, Hou FF and Zhou L (2019) Wnt/beta-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction. Aging Cell 18:e13004. doi: 10.1111/acel.13004
22.Qian L, Hong J, Zhang Y, Zhu M, Wang X, Zhang Y, Chu M, Yao J and Xu D (2018) Downregulation of S100A4 Alleviates Cardiac Fibrosis via Wnt/beta -Catenin Pathway in Mice. Cell Physiol Biochem 46:2551-2560. doi: 10.1159/000489683
23.Jeong MH, Kim HJ, Pyun JH, Choi KS, Lee DI, Solhjoo S, O'Rourke B, Tomaselli GF, Jeong DS, Cho H and Kang JS (2017) Cdon deficiency causes cardiac remodeling through hyperactivation of WNT/beta-catenin signaling. Proc Natl Acad Sci U S A 114:E1345-E1354. doi: 10.1073/pnas.1615105114
24.Kakugawa S, Langton PF, Zebisch M, Howell S, Chang TH, Liu Y, Feizi T, Bineva G, O'Reilly N, Snijders AP, Jones EY and Vincent JP (2015) Notum deacylates Wnt proteins to suppress signalling activity. Nature 519:187-192. doi: 10.1038/nature14259
25.Pentinmikko N, Iqbal S, Mana M, Andersson S, Cognetta AB, 3rd, Suciu RM, Roper J, Luopajarvi K, Markelin E, Gopalakrishnan S, Smolander OP, Naranjo S, Saarinen T, Juuti A, Pietilainen K, Auvinen P, Ristimaki A, Gupta N, Tammela T, Jacks T, Sabatini DM, Cravatt BF, Yilmaz OH and Katajisto P (2019) Notum produced by Paneth cells attenuates regeneration of aged intestinal epithelium. Nature 571:398-402. doi: 10.1038/s41586-019-1383-0
26.Cai B, Tan X, Zhang Y, Li X, Wang X, Zhu J, Wang Y, Yang F, Wang B, Liu Y, Xu C, Pan Z, Wang N, Yang B and Lu Y (2015) Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy. Stem Cells Transl Med 4:1425-35. doi: 10.5966/sctm.2015-0032
27.Ma H, Killaars AR, DelRio FW, Yang C and Anseth KS (2017) Myofibroblastic activation of valvular interstitial cells is modulated by spatial variations in matrix elasticity and its organization. Biomaterials 131:131-144. doi: 10.1016/j.biomaterials.2017.03.040
28.Sapudom J, Rubner S, Martin S, Thoenes S, Anderegg U and Pompe T (2015) The interplay of fibronectin functionalization and TGF-beta1 presence on fibroblast proliferation, differentiation and migration in 3D matrices. Biomater Sci 3:1291-301. doi: 10.1039/c5bm00140d
29.Nagaraju CK, Robinson EL, Abdesselem M, Trenson S, Dries E, Gilbert G, Janssens S, Van Cleemput J, Rega F, Meyns B, Roderick HL, Driesen RB and Sipido KR (2019) Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure. J Am Coll Cardiol 73:2267-2282. doi: 10.1016/j.jacc.2019.02.049
30.Voss AK, Krebs DL and Thomas T (2006) C3G regulates the size of the cerebral cortex neural precursor population. EMBO J 25:3652-63. doi: 10.1038/sj.emboj.7601234
31.Detienne G, De Haes W, Mergan L, Edwards SL, Temmerman L and Van Bael S (2018) Beyond ROS clearance: Peroxiredoxins in stress signaling and aging. Ageing Res Rev 44:33-48. doi: 10.1016/j.arr.2018.03.005
32.Gourdie RG, Dimmeler S and Kohl P (2016) Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug Discov 15:620-638. doi: 10.1038/nrd.2016.89
33.Porter KE and Turner NA (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123:255-78. doi: 10.1016/j.pharmthera.2009.05.002
34.Frangogiannis NG (2019) Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med 65:70-99. doi: 10.1016/j.mam.2018.07.001
35.van Nieuwenhoven FA and Turner NA (2013) The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vascul Pharmacol 58:182-8. doi: 10.1016/j.vph.2012.07.003
36.Logan CY and Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810. doi: 10.1146/annurev.cellbio.20.010403.113126
37.Nusse R and Clevers H (2017) Wnt/beta-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. Cell 169:985-999. doi: 10.1016/j.cell.2017.05.016
38.Huang H and He X (2008) Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol 20:119-25. doi: 10.1016/j.ceb.2008.01.009
39.Huang C and Ogawa R (2012) Fibroproliferative disorders and their mechanobiology. Connect Tissue Res 53:187-96. doi: 10.3109/03008207.2011.642035
40.Fu X, Khalil H, Kanisicak O, Boyer JG, Vagnozzi RJ, Maliken BD, Sargent MA, Prasad V, Valiente-Alandi I, Blaxall BC and Molkentin JD (2018) Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J Clin Invest 128:2127-2143. doi: 10.1172/JCI98215
41.Leask A (2015) Getting to the heart of the matter: new insights into cardiac fibrosis. Circ Res 116:1269-76. doi: 10.1161/CIRCRESAHA.116.305381
42.Pattabiraman PP, Maddala R and Rao PV (2014) Regulation of plasticity and fibrogenic activity of trabecular meshwork cells by Rho GTPase signaling. J Cell Physiol 229:927-42. doi: 10.1002/jcp.24524
43.Shinde AV, Humeres C and Frangogiannis NG (2017) The role of alpha-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta Mol Basis Dis 1863:298-309. doi: 10.1016/j.bbadis.2016.11.006
44.Bujak M and Frangogiannis NG (2007) The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184-95. doi: 10.1016/j.cardiores.2006.10.002
45.Khan R and Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 118:10-24. doi: 10.1111/j.1365-2567.2006.02336.x
46.Hernandez-Segura A, Nehme J and Demaria M (2018) Hallmarks of Cellular Senescence. Trends Cell Biol 28:436-453. doi: 10.1016/j.tcb.2018.02.001
47.Hoare M and Narita M (2013) Transmitting senescence to the cell neighbourhood. Nat Cell Biol 15:887-9. doi: 10.1038/ncb2811
48.Rayess H, Wang MB and Srivatsan ES (2012) Cellular senescence and tumor suppressor gene p16. Int J Cancer 130:1715-25. doi: 10.1002/ijc.27316